SHERRY R DAVIS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PINEHURST, NC NPI 1437883261

General Payments — all program years on this page

$3,775.60

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,216.70 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,216.7021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $246.152
2023 $2,312.7518
2024 $1,216.7021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104941113 SPR Therapeutics, Inc $149.03 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128474882 Bard Peripheral Vascular, Inc. $19.81 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128474890 Bard Peripheral Vascular, Inc. $14.05 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760053 Nevro Corp. $28.35 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760055 Nevro Corp. $30.48 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760057 Nevro Corp. $22.31 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760151 Nevro Corp. $139.64 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760153 Nevro Corp. $28.76 08/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760155 Nevro Corp. $36.10 08/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760157 Nevro Corp. $46.63 08/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760209 Nevro Corp. $125.47 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130760211 Nevro Corp. $145.00 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132915833 Curonix LLC $110.63 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133347283 Vertos Medical, Inc. $69.07 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135260741 Collegium Pharmaceutical, Inc. $19.80 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135278797 Collegium Pharmaceutical, Inc. $14.71 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135889607 Lilly USA, LLC $125.00 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144974244 Takeda Pharmaceuticals U.S.A., Inc. $19.02 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144974246 Takeda Pharmaceuticals U.S.A., Inc. $33.66 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144974248 Takeda Pharmaceuticals U.S.A., Inc. $25.37 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154828547 Pharmacosmos Therapeutics Inc. $13.81 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.